Company Reports Strong Quarterly Performance and Outlook
AUSTIN, Texas--(BUSINESS WIRE)--
Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance,
analog-intensive, mixed-signal integrated circuits (ICs), today reported
first quarter revenue of $125.7 million, a five percent increase
compared to the same period last year. GAAP and non-GAAP diluted
earnings per share of $0.33 and $0.43, respectively, also exceeded
expectations and represented solid growth versus the first quarter of
2011.
Financial Highlights
Strong new product cycles largely offset anticipated seasonal weakness,
driving revenue upside. First quarter revenue declined by less than one
percent sequentially, setting the stage for a strong start to 2012. On a
GAAP-basis, gross margin declined to 59.7 percent. R&D investment was
$32.9 million and SG&A expense was $25.4 million. Resulting GAAP
operating income was 13 percent, an improvement over the same period a
year ago. Net income was 11 percent of revenue. Diluted GAAP earnings
per share of 33 cents increased 14 percent sequentially, a six quarter
high.
The following non-GAAP results exclude the impact of stock compensation
and other one-time items. Significant strength in the company's video
products resulted in a mix shift during the quarter. Gross margin
therefore declined to 60.0 percent. R&D remained about flat at $29.3
million, while SG&A increased slightly to $23.3 million. Operating
income, therefore, was better than expected at 18 percent of revenue,
and net income was 15 percent of revenue. Solid operational results
provided significant earnings leverage resulting in diluted earnings per
share of 43 cents, a 7.5 percent year on year increase. Reconciling
charges are set forth in the financial measures table included below.
The company ended the quarter with $351 million in cash, cash
equivalents and investments due to continued healthy cash flow from
operations.
Business Highlights
First quarter revenue upside was driven by continued strength in video
and touch controllers, as well as solid demand for MCU and power-related
products.
The company's video products ramped into new design wins as TV makers
began to build their new models for 2012. Market share gains were behind
the more than 30 percent revenue growth compared to the same period a
year ago. Continued momentum at the company's large touch controller
customer also contributed to the first quarter performance as demand
outpaced original forecasts.
The MCU product line benefitted from some demand recovery in the
communications and industrial end markets, growing slightly sequentially
despite seasonal weakness in consumer end markets. Isolation and related
power product revenue also increased due to market share gains.
"As I take the helm, I see tremendous potential for the business. We
have the right team, the product line up and the market runway to become
one of the leaders in the semiconductor industry," said Tyson Tuttle,
president and CEO of Silicon Laboratories. "We're building a set of
capabilities that I feel strongly are going to be the backbone of a very
substantial and valuable piece of our business in the future."
The company expects revenue for the second quarter to be up three to
seven percent sequentially.
Webcast and Conference Call
A conference call discussing the quarterly results will follow this
press release at 7:30 a.m. central time. An audio webcast will be
available simultaneously on Silicon Laboratories' website under Investor
Relations (www.silabs.com).
A replay will be available after the call at the same website listed
above or by calling 1 (855) 859-2056 or +1 (404) 537-3406
(international) and by entering 71533415. The replay will be available
through May 9th.
About Silicon Laboratories Inc.
Silicon Laboratories Inc. is a leading designer of high-performance,
analog-intensive, mixed-signal integrated circuits (ICs) for a broad
range of applications. Silicon Laboratories' diverse portfolio of highly
integrated, patented solutions is developed by a world-class engineering
team with expertise in cutting-edge mixed-signal design. The company has
design, engineering, marketing, sales and applications offices
throughout North America, Europe and Asia. For more information about
Silicon Laboratories, please visit www.silabs.com.
Forward-Looking Statements
This press release contains forward-looking statements based on Silicon
Laboratories' current expectations. The words "believe," "estimate,"
"expect," "intend," "anticipate," "plan," "project," "will" and similar
phrases as they relate to Silicon Laboratories are intended to identify
such forward-looking statements. These forward-looking statements
reflect the current views and assumptions of Silicon Laboratories and
are subject to various risks and uncertainties that could cause actual
results to differ materially from expectations. Among the factors that
could cause actual results to differ materially from those in the
forward-looking statements are the following: risks that Silicon
Laboratories may not be able to maintain its historical growth;
quarterly fluctuations in revenues and operating results; volatile stock
price; average selling prices of products may decrease significantly and
rapidly; difficulties developing new products that achieve market
acceptance; dependence on a limited number of products and customers;
intellectual property litigation risks; inventory-related risks; risks
associated with acquisitions; difficulties managing international
activities; difficulties managing our manufacturers and subcontractors;
risks that Silicon Laboratories may not be able to manage strains
associated with its growth; credit risks associated with our accounts
receivable; dependence on key personnel; risks associated with
divestitures; geographic concentration of manufacturers, assemblers,
test service providers and customers in Asia that subjects Silicon
Laboratories' business and results of operations to risks of natural
disasters, epidemics, war and political unrest; the competitive and
cyclical nature of the semiconductor industry and other factors that are
detailed in Silicon Laboratories' filings with the SEC. Silicon
Laboratories disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new information,
future events or otherwise.
Note to editors: Silicon Laboratories, Silicon Labs and the Silicon
Labs logo are trademarks of Silicon Laboratories Inc. All other product
names noted herein may be trademarks of their respective holders.
|
|
|
|
|
Silicon Laboratories Inc.
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
2012
|
|
|
April 2,
2011
|
|
Revenues
|
|
$
|
125,702
|
|
|
|
$
|
119,636
|
|
|
Cost of revenues
|
|
|
50,606
|
|
|
|
|
47,478
|
|
|
Gross margin
|
|
|
75,096
|
|
|
|
|
72,158
|
|
|
Operating expenses:
|
|
|
|
|
|
|
Research and development
|
|
|
32,930
|
|
|
|
|
35,359
|
|
|
Selling, general and administrative
|
|
|
25,402
|
|
|
|
|
31,860
|
|
|
Operating expenses
|
|
|
58,332
|
|
|
|
|
67,219
|
|
|
Operating income
|
|
|
16,764
|
|
|
|
|
4,939
|
|
|
Other income (expense):
|
|
|
|
|
|
|
Interest income
|
|
|
497
|
|
|
|
|
571
|
|
|
Interest expense
|
|
|
(33
|
)
|
|
|
|
(5
|
)
|
|
Other income (expense), net
|
|
|
(111
|
)
|
|
|
|
209
|
|
|
Income before income taxes
|
|
|
17,117
|
|
|
|
|
5,714
|
|
|
Provision for income taxes
|
|
|
2,797
|
|
|
|
|
7,674
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
14,320
|
|
|
|
$
|
(1,960
|
)
|
|
|
|
|
|
|
|
|
Earnings (loss) per share:
|
|
|
|
|
|
|
Basic |
|
$
|
0.34
|
|
|
|
$
|
(0.04
|
)
|
|
Diluted
|
|
$
|
0.33
|
|
|
|
$
|
(0.04
|
)
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding:
|
|
|
|
|
|
|
Basic |
|
|
42,458
|
|
|
|
|
44,269
|
|
|
Diluted
|
|
|
43,850
|
|
|
|
|
44,269
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Income Statement Items
|
|
Three Months Ended
March 31, 2012
|
|
|
|
GAAP
Measure
|
|
|
GAAP
Percent of
Revenue
|
|
|
Stock
Compensation
Expense *
|
|
|
Termination
Costs **
|
|
|
Acquisition
Related
Items
|
|
|
Non-GAAP
Measure
|
|
|
Non-GAAP
Percent of
Revenue
|
|
Revenues
|
|
$
|
125,702
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
75,096
|
|
|
|
59.7
|
%
|
|
|
$
|
360
|
|
|
$
|
--
|
|
|
|
$
|
--
|
|
|
|
$
|
75,456
|
|
|
60.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
32,930
|
|
|
|
26.2
|
%
|
|
|
|
3,602
|
|
|
|
--
|
|
|
|
|
--
|
|
|
|
|
29,328
|
|
|
23.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
25,402
|
|
|
|
20.2
|
%
|
|
|
|
3,895
|
|
|
|
(868
|
)
|
|
|
|
(949
|
)
|
|
|
|
23,324
|
|
|
18.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
16,764
|
|
|
|
13.3
|
%
|
|
|
|
7,857
|
|
|
|
(868
|
)
|
|
|
|
(949
|
)
|
|
|
|
22,804
|
|
|
18.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
14,320
|
|
|
|
11.4
|
%
|
|
|
|
6,470
|
|
|
|
(1,133
|
)
|
|
|
|
(949
|
)
|
|
|
|
18,708
|
|
|
14.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Diluted Earnings Per Share
|
|
|
|
|
Three Months Ended
March 31, 2012
|
|
|
|
|
|
|
|
|
|
GAAP
Measure
|
|
|
Stock
Compensation
Expense *
|
|
|
Termination
Costs **
|
|
|
Acquisition
Related
Items
|
|
|
Non-GAAP
Measure
|
|
|
|
|
Net income
|
|
|
|
|
$
|
14,320
|
|
|
|
$
|
6,470
|
|
|
$
|
(1,133
|
)
|
|
|
$
|
(949
|
)
|
|
|
$
|
18,708
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted shares outstanding
|
|
|
|
43,850
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43,850
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share
|
|
|
$
|
0.33
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Excludes stock compensation recognized in connection with terminations
costs.
** Termination costs include the reversal of previously recognized stock
compensation for modified stock awards.
|
|
|
|
|
|
|
|
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
March 31,
2012
|
|
|
December 31,
2011
|
|
Assets
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
98,038
|
|
|
|
$
|
94,964
|
|
|
Short-term investments
|
|
|
235,299
|
|
|
|
|
212,526
|
|
|
Accounts receivable, net of allowances for doubtful accounts of
$925 at March 31, 2012 and $725 at December 31, 2011
|
|
|
61,425
|
|
|
|
|
55,351
|
|
|
Inventories
|
|
|
34,295
|
|
|
|
|
34,778
|
|
|
Deferred income taxes
|
|
|
4,941
|
|
|
|
|
11,563
|
|
|
Prepaid expenses and other current assets
|
|
|
47,527
|
|
|
|
|
43,867
|
|
|
Total current assets
|
|
|
481,525
|
|
|
|
|
453,049
|
|
|
Long-term investments
|
|
|
17,729
|
|
|
|
|
17,477
|
|
|
Property and equipment, net
|
|
|
24,008
|
|
|
|
|
25,141
|
|
|
Goodwill
|
|
|
115,489
|
|
|
|
|
115,489
|
|
|
Other intangible assets, net
|
|
|
57,725
|
|
|
|
|
60,005
|
|
|
Other assets, net
|
|
|
36,334
|
|
|
|
|
34,830
|
|
|
Total assets
|
|
$
|
732,810
|
|
|
|
$
|
705,991
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
29,965
|
|
|
|
$
|
26,354
|
|
|
Accrued expenses
|
|
|
30,810
|
|
|
|
|
30,857
|
|
|
Deferred income on shipments to distributors
|
|
|
28,269
|
|
|
|
|
24,962
|
|
|
Income taxes
|
|
|
1,302
|
|
|
|
|
665
|
|
|
Total current liabilities
|
|
|
90,346
|
|
|
|
|
82,838
|
|
|
Long-term obligations and other liabilities
|
|
|
19,053
|
|
|
|
|
24,214
|
|
|
Total liabilities
|
|
|
109,399
|
|
|
|
|
107,052
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
|
Preferred stock--$0.0001 par value; 10,000 shares authorized; no
shares issued and outstanding
|
|
|
--
|
|
|
|
|
--
|
|
|
Common stock--$0.0001 par value; 250,000 shares authorized; 42,835
and 42,068 shares issued and outstanding at March 31, 2012 and
December 31, 2011, respectively
|
|
|
4
|
|
|
|
|
4
|
|
|
Additional paid-in capital
|
|
|
24,251
|
|
|
|
|
14,749
|
|
|
Retained earnings
|
|
|
600,973
|
|
|
|
|
586,653
|
|
|
Accumulated other comprehensive loss
|
|
|
(1,817
|
)
|
|
|
|
(2,467
|
)
|
|
Total stockholders' equity
|
|
|
623,411
|
|
|
|
|
598,939
|
|
|
Total liabilities and stockholders' equity
|
|
$
|
732,810
|
|
|
|
$
|
705,991
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
2012
|
|
|
April 2,
2011
|
|
Operating Activities
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
14,320
|
|
|
|
$
|
(1,960
|
)
|
|
Adjustments to reconcile net income (loss) to cash provided by
(used in) operating activities:
|
|
|
|
|
|
|
Depreciation of property and equipment
|
|
|
3,543
|
|
|
|
|
3,253
|
|
|
Amortization of other intangible assets and other assets
|
|
|
2,280
|
|
|
|
|
3,057
|
|
|
Stock-based compensation expense
|
|
|
6,693
|
|
|
|
|
9,473
|
|
|
Income tax benefit from employee stock-based awards
|
|
|
2,656
|
|
|
|
|
1,184
|
|
|
Excess income tax benefit from employee stock-based awards
|
|
|
(2,426
|
)
|
|
|
|
(1,142
|
)
|
|
Deferred income taxes
|
|
|
3,101
|
|
|
|
|
1,366
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(6,074
|
)
|
|
|
|
(11,704
|
)
|
|
Inventories
|
|
|
447
|
|
|
|
|
(759
|
)
|
|
Prepaid expenses and other assets
|
|
|
4,581
|
|
|
|
|
(4,499
|
)
|
|
Accounts payable
|
|
|
4,209
|
|
|
|
|
(4,787
|
)
|
|
Accrued expenses
|
|
|
(5,087
|
)
|
|
|
|
(1,634
|
)
|
|
Deferred income on shipments to distributors
|
|
|
3,307
|
|
|
|
|
2,293
|
|
|
Income taxes
|
|
|
(5,403
|
)
|
|
|
|
3,233
|
|
|
Net cash provided by (used in) operating activities
|
|
|
26,147
|
|
|
|
|
(2,626
|
)
|
|
Investing Activities
|
|
|
|
|
|
|
Purchases of available-for-sale investments
|
|
|
(82,845
|
)
|
|
|
|
(31,492
|
)
|
|
Proceeds from sales and maturities of marketable securities
|
|
|
60,518
|
|
|
|
|
55,092
|
|
|
Purchases of property and equipment
|
|
|
(2,428
|
)
|
|
|
|
(2,697
|
)
|
|
Purchases of other assets
|
|
|
(850
|
)
|
|
|
|
(584
|
)
|
|
Acquisition of business, net of cash acquired
|
|
|
--
|
|
|
|
|
(27,546
|
)
|
|
Net cash used in investing activities
|
|
|
(25,605
|
)
|
|
|
|
(7,227
|
)
|
|
Financing Activities
|
|
|
|
|
|
|
Proceeds from issuance of common stock, net of shares withheld for
taxes
|
|
|
106
|
|
|
|
|
(3,580
|
)
|
|
Excess income tax benefit from employee stock-based awards
|
|
|
2,426
|
|
|
|
|
1,142
|
|
|
Repurchases of common stock
|
|
|
--
|
|
|
|
|
(606
|
)
|
|
Payments on debt
|
|
|
--
|
|
|
|
|
(7,174
|
)
|
|
Net cash provided by (used in) financing activities
|
|
|
2,532
|
|
|
|
|
(10,218
|
)
|
|
|
|
|
|
|
|
|
Increase (decrease) in cash and cash equivalents
|
|
|
3,074
|
|
|
|
|
(20,071
|
)
|
|
Cash and cash equivalents at beginning of period
|
|
|
94,964
|
|
|
|
|
138,567
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
98,038
|
|
|
|
$
|
118,496
|
|
Silicon Laboratories Inc.
Shannon Pleasant, 512-464-9254
shannon.pleasant@silabs.com
Source: Silicon Laboratories Inc.
News Provided by Acquire Media